Lynch syndrome (LS) is a prevalent cancer predisposition syndrome, originally defined by the Amsterdam criteria [1, 2] and later by pathogenic or likely pathogenic germline variants of the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, or PMS2 [3]. This evidence concerns the gene MSH2 and Leigh syndrome.